Biotechnology Focus Podcast

In this episode of the Biotechnology Focus Radio, Liam Kaufman, co-founder of Winterlight Labs discusses with us how AI is powering his company’s speech-based diagnostic platform. This platform natural speech to detect and monitor dementia, aphasia, and various cognitive conditions. About Winterlight Labs: WinterLight Labs is developing a proprietary AI diagnostic platform that can objectively assess and monitor cognitive health. The company's platform can analyze natural speech to detect and monitor dementia, aphasia, and various cognitive conditions. Using a short one-minute sample of speech, WinterLight can characterize the speaker's cognitive, acoustic and linguistic state, including lexical diversity, syntactic complexity, semantic content, and articulation. Using samples of a person’s speech, WinterLight’s platform analyzes hundreds of linguistic cues and can detect dementia of the Alzheimer type and other conditions with accuracies between 82% and 100%, as reported in our peer-reviewed academic studies